InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (0 oper.)
▼ Ventas (2 oper.)
Historial del iniciado
ConsejeroCompras declaradas
0
Ventas declaradas
2
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the detailed record of transactions filed by Berkman Charles S, Vice-Président Senior, Conseiller Général et Secrétaire. Officer active across 3 companies, notably Ligand Pharmaceuticals INC. Aggregated, 27 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €43k. Activity tracked since 26 January 2022. The latest transaction was disclosed on 7 April 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Berkman Charles S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones27 en total
7157 títulos@ 1,49 US$8.6% de su flujoCommon StockSEC:0001628280-26-024131:1
13.542 títulos0Common StockSEC:0001628280-26-024131:0
18.750 títulos0Common StockSEC:0001392266-26-000002:0
13.542 títulos0Common StockSEC:0001628280-26-008704:0
15.621 títulos0Common StockSEC:0001392266-25-000006:0
13.542 títulos0Common StockSEC:0001628280-25-016991:0
15.615 títulosCommon StockSEC:0001846253-25-000012:0
45.294 títulos0Common StockSEC:0001846253-25-000006:0
15.621 títulosCommon StockSEC:0001846253-24-000099:0
366.511 títulosCommon StockSEC:0001846253-24-000012:0
6954 títulos@ 5,27 US$31.7% de su flujoCommon StockSEC:0002001011-24-000044:1
13.541 títulosCommon StockSEC:0002001011-24-000044:0
15.624 títulosCommon StockSEC:0002001011-24-000020:0
17.556 títulosCommon StockSEC:0002001011-24-000004:0
15.622 títulosCommon StockSEC:0002001011-23-000008:0
40.625 títulos0Common StockSEC:0001846253-23-000041:0
1973 títulos@ 3,80 US$6.6% de su flujoCommon StockSEC:0001846253-23-000016:0
46.864 títulos0Common StockSEC:0000899243-23-001020:0
6518 títulos@ 3,66 US$21.1% de su flujoCommon StockSEC:0000899243-22-039582:0
10.580 títulos@ 3,35 US$32.0% de su flujoCommon StockSEC:0000899243-22-037744:0
15.409 títulos0Common StockSEC:0000899243-22-035045:0
353.716 títulosCommon StockSEC:0000899243-22-035063:0
11.944 títulosCommon StockSEC:0000899243-22-035038:0
5375 títulos0Common StockSEC:0000886163-22-000093:0
368 títulos@ 123,68 US$100.0% de su flujoCommon StockSEC:0000886163-22-000024:0
25 de 27 declaraciones
About Berkman Charles S
Berkman Charles S is Senior Vice President, General Counsel and Secretary. He has 27 filings in total. In the sampled recent filings from 2016-02-16 to 2026-04-07, sales total 42859 EUR and the most frequent transaction nature is option exercise. His listed companies are OmniAb, Inc., Ligand Pharmaceuticals INC and OmniAb Operations, Inc.
